Links

Homepage

Stock List

Search by Ticker

News

Login

Merck & Company (NYSE:MRK)
Stock Analysis

MRK81.02
▼ -0.04%-0.03

Stock Analysis

The following stock analysis is based on 8 years of data (i.e. since Jul 23, 2012). All the stock history has been downloaded.

Stock Exchange

Merck & Company trades on the NYSE exchange in USD dollars.

Sector

It is in the healthcare sector.

Current Status of Merck & Company

It is currently trading at $81.02 ($81.05 the previous day).It pays a 2.86% dividend.

Financials

The next reporting date is in 80 days (2020 10 27).

CNN estimates profits for the upcoming quarter will be $1.41 per share ($12.1B). The current Canada / US exchange rate is 1.3382.



Over the past 12 months, $0 worth of shares have been purchased and $17560158 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 6.8% per year assuming steady exponential growth. The actual 5 year average is 7.84. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year82.5921948113218.3+ Above Average
2 year76.28927312775328.7+ Above Average
3 year59.26719665272-5.7- Below Average
4 year62.84268292682915.3+ Above Average
5 year54.492264150943-7.4- Below Average
Merck & Company is projected by analysts to get to $92.00 within the next 12 months (13.6%), but preticted targets range from as high as $107.00 (32.1%) and as low as $84(3.7%).

Risk

The worst drop it has had in recent years is -27.5%. It has a few bumps shape to the stock curve, which means the stock generally continues on a consistent trend and does not have to be checked often, but can have some variation during periods of volitility.

Stock shape test

DAYS AG0PRICE
1077.1RISING
3078.78DROPPING
6082.26DROPPING
15079.66RISING
36584.35DROPPING
80059.72RISING
120062.3DROPPING
160052.8RISING
200058.81DROPPING


With an average increase of 6.8% year over year, if Merck & Company is bought at the worst time, Stockmarketizer analysts estimate it will take 48.5 months before the stock will recover to the original purchase price. The P/E value is 19.74. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.

Tradingview BuySell Widget

Yahoo News Feed

Johnson and Johnson stock outperforms market on strong trading day

Fri, 07 Aug 2020 20:25:00 COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson and Johnson JNJ inched 0.71% higher to $148.60 Friday, on what proved to be an all-around favorable trading session for the stock market, with the SandP 500 Index SPX rising 0.... Read Full Article

Cisco, Chevron share losses contribute to Dowand's 25-point fall

Fri, 07 Aug 2020 15:08:00 DOW UPDATE Dragged down by losses for shares of Cisco and Chevron, the Dow Jones Industrial Average is declining Friday morning. The Dow (DJIA) was most recently trading 28 points (0.1%) lower, as shares of Cisco (CSCO) and Chevron (CVX) are contributing ...... Read Full Article

NIH to test remdesivir with Merck KGaAand's interferon therapy as a COVID-19 treatment

Fri, 07 Aug 2020 13:11:00 The National Institutes of Health said it will conduct a randomized, controlled clinical trial testing a combination of Gilead Sciences Inc.and's remdesivir with Merck KGaAand's interferon beta-1a as a treatment for COVID-19 patients. The study plans to enroll 1,000 ...... Read Full Article

Johnson and Johnson stock falls Thursday, underperforms market

Thu, 06 Aug 2020 20:25:00 COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson and Johnson JNJ dropped 0.57% to $147.55 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the SandP 500 Index SPX rising 0.... Read Full Article

Early Sales of Eli Lillyand's Migraine Drug Disappoint

Thu, 06 Aug 2020 17:42:51 The company is confident Reyvow will reach $13 billion by 2027 Continue reading...... Read Full Article

Kahn Brothers Cuts Merck and Co., Hologic

Thu, 06 Aug 2020 16:54:16 Firmand's largest sales of the 2nd quarter Continue reading...... Read Full Article

Dow Jones Leads As Apple Eyes New High; Stocks Mixed After Jobless Claims Data

Thu, 06 Aug 2020 16:31:08 Stocks sought direction midday after the jobless claims report as the Dow Jones Industrial Average edged higher but the SandP; 500 slipped.... Read Full Article

Bristol Myers lifts annual profit view on hopes of pickup in patient visits to doctors

Thu, 06 Aug 2020 10:59:01 Bristol Myers Squibb Co raised its annual profit forecast on Thursday on hopes of a recovery in demand for its hospital-administered drugs, which had dropped as patients stayed away from doctors' offices due to the COVID-19 pandemic. The U.S. ...... Read Full Article

The stock market will be flying high in a year — for 2 simple reasons

Wed, 05 Aug 2020 15:18:00 Stock markets love to take everyone by surprise, and less than a year from now a very big surprise will have played out: Stocks will be a lot higher by June as the economy moves into overheat mode. How do ...... Read Full Article

Merck Animal Health Completes Acquisition of IdentiGEN

Wed, 05 Aug 2020 11:00:00 Merck Animal Health Completes Acquisition of IdentiGEN... Read Full Article

Johnson and Johnson stock falls Tuesday, underperforms market

Tue, 04 Aug 2020 20:25:00 COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson and Johnson JNJ slid 0.09% to $147.22 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the SandP 500 Index SPX rising 0.... Read Full Article

Merck, Hanmi Seal Licence Deal For Fatty Liver Disease Therapy

Tue, 04 Aug 2020 12:06:34 Merck and Co. and Hanmi Pharmaceutical on Tuesday entered into an exclusive licensing agreement to develop efinopegdutide (formerly HM12525A), an investigational once-weekly therapy for the treatment of nonalcoholic steatohepatitis (NASH), a type of liver disease tied to obesity.Under ...... Read Full Article

Goldman Upgrades Merck To Buy, Lifts PT

Tue, 04 Aug 2020 10:07:02 Goldman Sachs on Monday upgraded pharma giant Merck and Co. to Buy from Hold, citing its strong pipeline and cancer drug Keytruda.Goldman analyst Terence Flynn lifted Merckand's (MRK) price target to $105 (27.2% upside potential) from $91, saying “the market seems to ...... Read Full Article

Merck and Hanmi Pharmaceutical Enter into Licensing Agreement to Develop Efinopegdutide, an Investigational Once-Weekly Therapy for Nonalcoholic Steatohepatitis (NASH)

Tue, 04 Aug 2020 09:00:00 Merck and Hanmi Pharmaceutical Enter into Licensing Agreement to Develop Efinopegdutide, an Investigational Once-Weekly Therapy for NASH... Read Full Article

Dow Jones Gets Microsoft Boost, Nasdaq Hits New High In Broad Stock Market Rally

Mon, 03 Aug 2020 20:28:54 Stocks rallied Monday as ongoing coronavirus stimulus talks and Microsoftand's TikTok news boosted the Dow Jones Industrial Average.... Read Full Article

Johnson and Johnson stock rises Monday, outperforms market

Mon, 03 Aug 2020 20:25:00 COMPANY CLOSE UPDATES Terrence Horan Shares of Johnson and Johnson JNJ rose 1.09% to $147.35 Monday, on what proved to be an all-around positive trading session for the stock market, with the SandP 500 Index SPX rising 0.... Read Full Article

Dow Jones Jumps 250 Points, Led By Microsoft, Apple; 5 Software Stocks To Watch With Earnings Due Soon

Mon, 03 Aug 2020 19:06:26 The Dow Jones was up nicely in afternoon trading Monday, helped by strong performances from Microsoft, Apple and Merck.... Read Full Article

Microsoft, Apple Inc. share gains contribute to Dowand's nearly 275-point rally

Mon, 03 Aug 2020 18:24:00 DOW UPDATE Shares of Microsoft and Apple Inc. are seeing positive momentum Monday afternoon, propelling the Dow Jones Industrial Average rally. The Dow (DJIA) was most recently trading 270 points higher (1.... Read Full Article

Company News for Aug 3, 2020

Mon, 03 Aug 2020 16:54:04 Companies In The News Are: MRK, CVX, NOK, CHD.... Read Full Article
<